07-09-2009: Life Technologies Corporation announced it has signed a definitive agreement to sell its ownership stake in its mass spectrometry business, operated as a joint venture, to Danaher Corporation for $450 million in cash. Danaher has also signed an agreement to acquire Life Technologies’ joint venture partner in the mass spectrometry business, MDS Analytical Technologies, a division of MDS Inc. The transaction is expected to close in the fourth quarter of 2009.
“The sale of our mass spectrometry business will enable us to continue our focus on our core competencies,” said Greg Lucier, Chairman and Chief Executive Officer of Life Technologies. “By concentrating on biological solutions that leverage our expertise in DNA, RNA, proteins and cells, we will continue to drive breakthroughs in life science research, genomic medicine, molecular diagnostics and applied markets.”
Life Technologies does not expect the sale of its mass spectrometry business to affect its previously announced full year 2009 earnings expectations. In addition, the company reiterated its synergy targets for the Invitrogen and Applied Biosystems merger of $95 million in 2009 and $175 million by 2011.
The transaction is subject to customary closing conditions, and is also conditioned upon the completion of MDS Inc.’s sale of its Analytical Technologies division, which itself is conditioned upon approval from MDS’ shareholders. The transaction is expected to close in the fourth quarter of 2009 and is not subject to any financing conditions. Moelis & Company and Thomas Weisel Partners are acting as financial advisors and DLA Piper is serving as legal counsel to Life Technologies.
Life Technologies Corporation announced it has signed a definitive agreement to sell its ownership stake in its mass spectrometry business, operated as a joint venture, to Danaher Corporation for $450 million in cash. Danaher has also signed an agreement to acquire Life Technologies’ joint ... more
MDS Analytical Technologies announced it has acquired California-based Blueshift Biotechnologies (Sunnyvale, CA) for $13 million. The acquisition of Blueshift Biotechnologies, a developer of screening platforms for life sciences research and maker of the IsoCyte(TM) benchtop laser scanning ... more
Scientists at the Spanish Council for Scientific Research (CSIC) in Barcelona have developed a new method for monitoring the consumption of drugs of abuse in the general population. This method, which was developed using analytical laboratory technology from Applied Biosystems/MDS Analytica ... more
Danaher Corporation announced that it has entered into a definitive merger agreement with Beckman Coulter, Inc. pursuant to which Danaher will acquire Beckman Coulter by making a cash tender offer to acquire all of the outstanding shares of common stock of Beckman Coulter at a purchase ... more
Life Technologies Corporation announced it has signed a definitive agreement to sell its ownership stake in its mass spectrometry business, operated as a joint venture, to Danaher Corporation for $450 million in cash. Danaher has also signed an agreement to acquire Life Technologies’ joint ... more
Danaher Corporation announced that it has signed a definitive agreement to purchase German-based Leica Microsystems AG from LM Investments S.à r.l. The purchase price amounts to an enterprise value of approximately EUR450 million, including assumed debt, pension liabilities, transaction cos ... more
Thermo Fisher Scientific and Life Technologies Corporation have signed a definitive agreement under which Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of net debt at close ($2.2 billion as ... more
Life Technologies Corporation announced it has signed a definitive agreement to sell its ownership stake in its mass spectrometry business, operated as a joint venture, to Danaher Corporation for $450 million in cash. Danaher has also signed an agreement to acquire Life Technologies’ joint ... more